Literature DB >> 8578837

Absence of an association between rubella vaccination and arthritis in underimmune postpartum women.

P E Slater1, T Ben-Zvi, A Fogel, M Ehrenfeld, S Ever-Hadani.   

Abstract

In a double-blind historical cohort study, 485 underimmune women who received rubella vaccine post-partum during 1985-1990 and 493 controls matched for age, place of residence and date of delivery were queried by phone concerning joint complaints following the pregnancy in question. Those reporting joint symptoms were invited for a personal interview at which joint symptoms and dates of their occurrence were explored in detail. Nineteen women in the vaccinated group (3.9%) and 16 from the control group (3.2%) were judged to have had joint symptoms compatible with the study definition of arthritis. The difference was not statistically significant. Thus, we were unable to find evidence for an association between rubella vaccination of underimmune adult women vaccinated post-partum and the subsequent development of arthritis. Rubella vaccine should continue to be used to immunize susceptible adult women against rubella in order to further the goal of elimination of the congenital rubella syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578837     DOI: 10.1016/0264-410x(95)00096-j

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

Review 2.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

Authors:  S E Robertson; F T Cutts; R Samuel; J L Diaz-Ortega
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Revaccination against measles and rubella.

Authors:  F T Cutts
Journal:  BMJ       Date:  1996-03-09

4.  Autoantigens interact with cis-acting elements of rubella virus RNA.

Authors:  G P Pogue; J Hofmann; R Duncan; J M Best; J Etherington; R D Sontheimer; H L Nakhasi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Rubella virus and chronic joint disease: is there an association?

Authors:  T J Bosma; J Etherington; S O'Shea; K Corbett; F Cottam; L Holt; J E Banatvala; J M Best
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 6.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

Review 7.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

Review 8.  Measles vaccines: a review of adverse events.

Authors:  P Duclos; B J Ward
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.228

Review 9.  A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?

Authors:  Teresa Lambe; Georgina Bowyer; Katie J Ewer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

Review 10.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.